[{"id":"eaacbaad-f813-44b5-b98c-4ef8fd4a5156","acronym":"","url":"https://clinicaltrials.gov/study/NCT07480863","created_at":"2026-03-28T01:39:30.077Z","updated_at":"2026-03-28T01:39:30.077Z","phase":"Phase 2","brief_title":"Treatment of BTKi+Hi-CVP Regimen for Previously Untreated MZL","source_id_and_acronym":"NCT07480863","lead_sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","biomarkers":" CD20","pipe":" | ","alterations":" CD20 positive","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD20 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • vincristine • Inokai (orelabrutinib) • Anruixi (zuberitamab)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 65","initiation":"Initiation: 10/01/2025","start_date":" 10/01/2025","primary_txt":" Primary completion: 10/01/2029","primary_completion_date":" 10/01/2029","study_txt":" Completion: 10/02/2029","study_completion_date":" 10/02/2029","last_update_posted":"2026-03-18"},{"id":"e5e0e642-1bb1-4ffb-bc52-619abeba57cc","acronym":"","url":"https://clinicaltrials.gov/study/NCT03485118","created_at":"2021-01-18T17:10:02.912Z","updated_at":"2024-07-02T16:37:11.901Z","phase":"Phase 2","brief_title":"RHCACD20MA (HS006) Combined With CHOP (Hi-CHOP) in Patients With Previously Untreated Diffuse Large B-cell Lymphoma","source_id_and_acronym":"NCT03485118","lead_sponsor":"Zhejiang Hisun Pharmaceutical Co. Ltd.","biomarkers":" CD20","pipe":" | ","alterations":" CD20 positive","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD20 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Rituxan (rituximab) • doxorubicin hydrochloride • cyclophosphamide • Anruixi (zuberitamab)"],"overall_status":"Completed","enrollment":" Enrollment 137","initiation":"Initiation: 05/12/2016","start_date":" 05/12/2016","primary_txt":" Primary completion: 08/12/2016","primary_completion_date":" 08/12/2016","study_txt":" Completion: 01/14/2018","study_completion_date":" 01/14/2018","last_update_posted":"2018-04-02"}]